Abstract

Two new formamidinate-bridged Rh2II,II complexes, cis-[Rh2II,II(μ-DTolF)2(μ-np)2]2+ (3; DTolF=N,N′-di-p-tolylformamidinate; np=1,8-naphthyridine) and cis-[Rh2II,II(μ-DTolF)2(κ2-dap)2]2+ (4; dap=1,12-diazaperylene), were synthesized from cis-[Rh2II,II(μ-DTolF)2(CH3CN)6](BF4)2 (1), and their properties were compared to those of cis-[Rh2II,II(μ-DTolF)2(phen)2](BF4)2 (2). Density functional theory (DFT) and electrochemical analyses support the description of the highest occupied molecular orbitals (HOMOs) of 3 and 4 as possessing contributions from the metals and formamidinate bridging ligands, with Rh2/form character, and lowest unoccupied molecular orbitals (LUMOs) localized on the respective diimine ligand np and dap π∗ orbitals. Both 3 and 4 display strong, low energy Rh2/form→diimine(π∗) metal/ligand-to-ligand charger transfer (1ML–LCT) transitions with maxima at 566nm (ε=3600M−1cm−1) for 3 and at 630nm (ε=2900M−1cm−1) for 4 in CH3CN. Time dependent-DFT (TD-DFT) calculations support these assignments. The ability of both the bridging np and chelating dap diimine ligands to produce strong absorption of these Rh2II,II complexes throughout the visible region is potentially useful for the development of new photocatalysts for H2 production and photochemotherapeutics.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.